Similar compounds searching system by using the gene expression microarray database

Toxicology Letters

Volumn 186, Issue 1, 2009, Pages 52-57

  Toyoshiba, Hiroyoshi ^a   Sawada, Hiroshi ^a   Naeshiro, Ichiro ^a   Horinouchi, Akira ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Fold change ranking; Gene expression; Microarray database; Similar compounds searching system

Indexed keywords

CLOFIBRATE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; GENE EXPRESSION; GENE MAPPING; JAPAN; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SIMILAR COMPOUND SEARCHING SYSTEM; TOXICOGENETICS;

ADMINISTRATION, ORAL; ANIMALS; DATABASES, FACTUAL; GENE EXPRESSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOGENETICS; XENOBIOTICS;

RATTUS;

EID: 61349126145     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2008.08.009     Document Type: Article

References (28)

1. Barros S.A. The importance of applying toxicogenomics to increase the efficiency of drug discovery. Pharmacogenomics 6 (2005) 547-550
2. Bichet N., Cahard D., Fabre G., Remandet B., Gouy D., and Cano J.P. Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture. Toxicol. Appl. Pharmacol. 106 (1990) 509-517
3. Charlier C., Foidart J.M., Pitance F., Herman P., Gaspard U., Meurisse M., and Plomteux G. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?. Clin. Chem. Lab. Med. 42 (2004) 222-227
4. Copple B.L., Rondelli C.M., Maddox J.F., Hoglen N.C., Ganey P.E., and Roth R.A. Modes of cell death in rat liver after monocrotaline exposure. Toxicol. Sci. 77 (2004) 172-182
5. DeRisi J.L., Iyer V.R., and Brown P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278 (1997) 680-686
6. Ganter B., Tugendreich S., Pearson C.I., Ayanoglu E., Baumhueter S., Bostian K.A., Brady L., Browne L.J., Calvin J.T., Day G.J., Breckenridge N., Dunlea S., Eynon B.P., Furness L.M., Ferng J., Fielden M.R., Fujimoto S.Y., Gong L., Hu C., Idury R., Judo M.S., Kolaja K.L., Lee M.D., McSorley C., Minor J.M., Nair R.V., Natsoulis G., Nguyen P., Nicholson S.M., Pham H., Roter A.H., Sun D., Tan S., Thode S., Tolley A.M., Vladimirova A., Yang J., Zhou Z., and Jarnagin K. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol. 119 (2005) 219-244
7. Guo L., Lobenhofer E.K., Wang C., Shippy R., Harris S.C., Zhang L., Mei N., Chen T., Herman D., Goodsaid F.M., Hurban P., Phillips K.L., Xu J., Deng X., Sun Y.A., Tong W., Dragan Y.P., and Shi L. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 24 (2006) 1162-1169
8. Gustafson D.L., Long M.E., Thomas R.S., Benjamin S.A., and Yang R.S. Comparative hepatocarcinogenicity of hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, and 1,4-dichlorobenzene: application of a medium-term liver focus bioassay and molecular and cellular indices. Toxicol. Sci. 53 (2000) 245-252
9. Hamadeh H.K., Knight B.L., Haugen A.C., Sieber S., Amin R.P., Bushel P.R., Stoll R., Blanchard K., Jayadev S., Tennant R.W., Cunningham M.L., Afshari C.A., and Paules R.S. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol. Pathol. 30 (2002) 470-482
10. Hollander M., and Wolfe D. Nonparametric Statistical Methods. second ed. (1999), Wiley, New York pp. 178-185
11. Kashfi K., McDougall C.J., and Dannenberg A.J. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clin. Pharmacol. Ther. 58 (1995) 625-630
12. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3 (2004) 711-715
13. Kurihara H., Sano N., and Takikawa H. Biliary excretion of taurocholate, organic anions and vinblastine in rats with alpha-naphthylisothiocyanate-induced cholestasis. J. Gastroenterol. Hepatol. 20 (2005) 1069-1074
14. Lamb J., Crawford E.D., Peck D., Modell J.W., Blat I.C., Wrobel M.J., Lerner J., Brunet J.P., Subramanian A., Ross K.N., Reich M., Hieronymus H., Wei G., Armstrong S.A., Haggarty S.J., Clemons P.A., Wei R., Carr S.A., Lander E.S., and Golub T.R. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313 (2006) 1929-1935
15. Lamb J., Ramaswamy S., Ford H.L., Contreras B., Martinez R.V., Kittrell F.S., Zahnow C.A., Patterson N., Golub T.R., and Ewen M.E. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114 (2003) 323-334
16. Mitra S.K., Venkataranganna M.V., Gopumadhavan S., and Sundaram R. Anti-cholestatic activity of HD-03, a herbal formulation in thioacetamide (TAA)-induced experimental cholestasis. Indian J. Exp. Biol. 37 (1999) 409-410
17. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstrale M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., and Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003) 267-273
18. Olsen J.H., Boice Jr. J.D., Jensen J.P., and Fraumeni Jr. F.J. Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81 (1989) 1753-1754
19. Parkinson H., Kapushesky M., Shojatalab M., Abeygunawardena N., Coulson R., Farne A., Holloway E., Kolesnykov N., Lilja P., Lukk M., Mani R., Rayner T., Sharma A., William E., Sarkans U., and Brazma A. ArrayExpress: a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 35 (2007) D747-750
20. Peraza M.A., Burdick A.D., Marin H.E., Gonzalez F.J., and Peters J.M. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol. Sci. 90 (2006) 269-295
21. Rosenberg F.J., and Cooke W.J. A peripheral component of centrally acting muscle relaxants: chlormezanone and mephenesin. J. Pharmacol. Exp. Ther. 155 (1967) 145-151
22. Sawada H., Takami K., and Asahi S. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol. Sci. 83 (2005) 282-292
23. Shi L., Tong W., Fang H., Scherf U., Han J., Puri R.K., Frueh F.W., Goodsaid F.M., Guo L., Su Z., Han T., Fuscoe J.C., Xu Z.A., Patterson T.A., Hong H., Xie Q., Perkins R.G., Chen J.J., and Casciano D.A. Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinform. 6 Suppl. 2 (2005) S12
24. Takashima K., Mizukawa Y., Morishita K., Okuyama M., Kasahara T., Toritsuka N., Miyagishima T., Nagao T., and Urushidani T. Effect of the difference in vehicles on gene expression in the rat liver: analysis of the control data in the Toxicogenomics Project Database. Life Sci. 78 (2006) 2787-2796
25. Tateishi T., Asoh M., Nakura H., Watanabe M., Tanaka M., Kumai T., and Kobayashi S. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chem. Biol. Interact. 117 (1999) 257-268
26. Tong W., Cao X., Harris S., Sun H., Fang H., Fuscoe J., Harris A., Hong H., Xie Q., Perkins R., Shi L., and Casciano D. ArrayTrack: supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ. Health Perspect. 111 (2003) 1819-1826
27. Wong A., and Bandiera S.M. Induction of hepatic cytochrome P450 2B and P450 3A isozymes in rats by zolazepam, a constituent of Telazol. Biochem. Pharmacol. 55 (1998) 201-207
28. Xirasagar S., Gustafson S.F., Huang C.C., Pan Q., Fostel J., Boyer P., Merrick B.A., Tomer K.B., Chan D.D., Yost III K.J., Choi D., Xiao N., Stasiewicz S., Bushel P., and Waters M.D. Chemical effects in biological systems (CEBS) object model for toxicology data, SysTox-OM: design and application. Bioinformatics 22 (2006) 874-882